New research by scientists at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM) demonstrates how dying or damaged brain cells release debris into the bloodstream and give rise to specific autoantibodies that appear to be reliable biomarkers for early diagnosis of Alzheimer's and other neurodegenerative ...

(Mayo Clinic) At Mayo Clinic, the name Clifford Jack Jr., M.D., means cutting-edge imaging and Alzheimer's research.

AUGUSTA, Ga. When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report. Amyloid is excreted by all neurons, but rates increase with aging ...

(Santa Barbara, Calif.) After an announcement by federal officials approving clinical trials for the drug Crenezumab, researchers searching for a way to treat Alzheimer's Disease are gearing up for a rare study that will allow them to test a therapy for a genetically predestined disease before its onset. ...

(Georgia Health Sciences University) When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.

Although there is a strong association between common mutations of the ApoE gene and the risk of developing late-onset Alzheimer's disease, researchers have not known what role this gene plays in the disease until now. Of the three varieties of ApoE - ApoE2, ApoE3 and ApoE4, the team found ...

(University of California - Santa Barbara) After an announcement by federal officials approving clinical trials for the drug Crenezumab, researchers searching for a way to treat Alzheimer's Disease are gearing up for a rare study that will allow them to test a therapy for a genetically predestined disease -- before ...

Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the ...

A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature.

Obama's healthcare goals have been controversial at best, and although anti-smoking campaigns and other public health and safety awareness drives have been successful, it's always somewhat dubious when government starts creating grand plans and lofty goals. Nonetheless, Health and Human Services Secretary Kathleen Sebelius has released an ambitious and wide ...

The plan, which includes an emphasis on research, sets 2025 as the target date for finding effective treatments for this disease.

(University of Rochester Medical Center) ApoE4, a well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report in the journal Nature.